Classement en actions
#30384
Aelis Farma S.A., a French biotechnology company founded in 2013 and... Aelis Farma S.A., a French biotechnology company founded in 2013 and headquartered in Bordeaux, is dedicated to the discovery and development of treatments for brain-related illnesses. The firm's research pipeline primarily focuses on signaling-specific inhibitors that target CB1 receptors. Its leading investigational drug, AEF0117, is currently advancing through Phase 2b clinical trials, designed to alleviate the harmful impacts of excessive cannabis consumption. Furthermore, AEF0217, another key drug candidate, has successfully completed Phase 1 clinical trials, with the goal of addressing cognitive impairments linked to Down syndrome and other similar conditions.
Prix de l'action
$1.25
Dernière synchronisation: 2026-08-18
Capitalisation boursière
$17.05M
Changement (1 jour)
-1.50%
Changement (1 an)
-22.24%
Échange Aelis Farma S.A. (AELIS)
Le prix AELIS avec la capitalisation boursière de B
Capitalisation boursière de Aelis Farma S.A.(AELIS)
Capitalisation boursière: $17.05M
En August 2026, Aelis Farma S.A. a une capitalisation boursière de $17.05M. Cela fait de Aelis Farma S.A. la 30384th entreprise la plus valorisée au monde selon nos données. La capitalisation boursière, souvent appelée market cap, correspond à la valeur totale des actions en circulation d’une entreprise cotée en bourse, et est couramment utilisée pour évaluer sa valeur.
Historique de la capitalisation boursière de Aelis Farma S.A. du 2022 au 2026
AELIS par rapport au top 5 des plus populaires stocks
| Prix pour AELIS |
|
L’actif B |
La capitalisation boursière de B |
Résultats |
|
|
|
|
$5.307T
|
+31,129,810.13%
|
|
|
|
|
$4.551T
|
+26,695,786.97%
|
|
|
|
|
$4.154T
|
+24,370,577.33%
|
|
|
|
|
$3.589T
|
+21,051,335.33%
|
|
|
|
|
$2.797T
|
+16,406,999.17%
|
